rs1045642, ABCB1

N. diseases: 214
Source: ALL
Disease Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
Leukopenia
CUI: C0023530
Disease: Leukopenia
0.100 GeneticVariation BEFREE Serum LDH may be a promising predictor of prognosis, and the ABCB1 C3435T polymorphism may be a genetic predictor of the severity of leukocytopenia in patients with CRPC treated with DEC. 21706123 2012
Leukopenia
CUI: C0023530
Disease: Leukopenia
0.100 GeneticVariation BEFREE PG analysis showed that ABCB1 (C3435T)T/T (membrane transport) was associated with IP-related diarrhea; UGT1A1 (G-3156A)A/A (drug metabolism) was associated with IP-related neutropenia. 19349543 2009
Leukopenia
CUI: C0023530
Disease: Leukopenia
0.100 GeneticVariation BEFREE Statistical associations were observed, suggesting a lower risk of neutropenia (p = 0.013) and hand-foot syndrome (HFS; p = 0.027) for the carriers of T variation for rs1128503 in capecitabine-treated patients, carriers of T variation for rs1045642 treated with capecitabine had a lower risk of HFS (p = 0.033), while those treated with 5-FU had a higher risk of diarrhea (p = 0.035), and carriers of T variation for rs2032592 treated with capecitabine were at less risk of developing HFS (p = 0.033). 21142915 2010
Leukopenia
CUI: C0023530
Disease: Leukopenia
0.100 GeneticVariation BEFREE In addition, a statistically significant association was found among neutropenia (absolute neutrophil count<500) and variant allele carriers of ABCB1 rs1045642 (OR=5.174; 95% CI: 1.674; 15.989) and ABCB1 rs1128503 (OR=3.364; 95% CI: 1.257; 9.004), respectively. 25007187 2014
Leukopenia
CUI: C0023530
Disease: Leukopenia
0.100 GeneticVariation BEFREE On evaluating higher order gene-gene interaction models by MDR analysis, CYP3A5*3; ABCB11236C>T and ABCB1 2677G>T/A; ABCB1 3435C>T and CYP1B1*3 showed significant association with treatment response, grade 2-4 anemia and dose delay/reduction due to neutropenia (P=0.024, P=0.004, P=0.026), respectively. 24704000 2014
Leukopenia
CUI: C0023530
Disease: Leukopenia
0.100 GeneticVariation BEFREE C3435T polymorphisms of ABCB1 might be able to predict severe amrubicin-induced neutropenia. 24982363 2014
Leukopenia
CUI: C0023530
Disease: Leukopenia
0.100 GeneticVariation BEFREE Associations were found between toxicities and gene variants (P<0.05), including neutropenia with ABCB1 (rs1045642) and SLC0B3 (rs4149117 and rs7311358); and diarrhoea with CYP2C9 (rs1057910), CYP2C19 (rs3758581), UGT1A6 (rs4124874) and SLC22A1 (rs72552763). 28817838 2017
Leukopenia
CUI: C0023530
Disease: Leukopenia
0.100 GeneticVariation BEFREE Individuals who were CC homozygotes at MDR1 rs1045642 had lower risk of having methotrexate plasma concentrations >1 μM and leukopenia grade I (odds ratio [OR] = 0.30; 95% CI = 0.13-0.72 and OR = 0.32; 95% CI = 0.14-0.72, respectively). 27533339 2016
Leukopenia
CUI: C0023530
Disease: Leukopenia
0.100 GeneticVariation BEFREE With regard to ABCB1 3435 C>T, ABCB1 3435 T/T had significantly higher risks of neutropenia (P = 0.015). 22271208 2012
Leukopenia
CUI: C0023530
Disease: Leukopenia
0.100 GeneticVariation BEFREE We found that patients carrying the CYP3A5*1/*3 genotype demonstrated more side effects of fever, pleural effusion, and febrile neutropenia than those with the CYP3A5*3/*3 genotype (p = 0.075, 0.077, and 0.030, respectively); moreover, patients with the ABCB1 2677G/G genotype also showed more side effects of fever and febrile neutropenia than those with other genotypes (p = 0.024 and 0.027), In regard to ABCB1 3435C>T, patients with ABCB1 3435C/C tended to suffer leucopenia (p = 0.057). 19332043 2009
Leukopenia
CUI: C0023530
Disease: Leukopenia
0.100 GeneticVariation BEFREE CYP2C8*3 and the ABCB1 SNPs C1236T, G2677T/A, and C3435T were not statistically significantly correlated to overall survival, sensoric neuropathy, and neutropenia in 119 patients treated for ovarian cancer with paclitaxel/carboplatin. 21327421 2011